News News Today | Latest News Updates

Retension Pharmaceuticals Appoints Alison Schecter, M.D., as Chief Medical Officer and Alex Schwartz as Chief Financial Officer

FALLS CHURCH, Va.--(BUSINESS WIRE)-- #CFO--Retension appoints Alison D. Schecter as CMO and Alex Schwartz as CFO as RTN-001 advances in a Phase 2b trial in hypertension.

Retension Pharmaceuticals Appoints Alison Schecter, M.D., as Chief Medical Officer and Alex Schwartz as Chief Financial Officer

In This Category

Get in Touch

Latest Post

Quick Links

Newsletter